ChineseChina UKUK DeutschlandDeutschland FranceFrance РоссияРоссия 한국한국 ไทยไทย Việt NamViệt Nam العربيةالعربية ҚазақстанҚазақстан EspañaEspaña MyanmarMyanmar DaiDai

Linking China’s Premium Healthcare · Serving Global Health Needs

Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties

One-Stop Medical Care in China

  • International flights · Airport pickup · Nearby hotels
  • Multilingual interpreters · Full medical escort
  • Expert matching · Hospital fast-track
  • Full-cycle treatment · Post-op follow-up
Sign in

Dr. Kenneth Favreys illness

Patient basic information Patient: Mr. Kenneth (Kenneth Smith) Nationality: Malaysia Disease Diagnosis: Fabre disease Diagnostic Hospital: H0C0 treatment plan: Blood stem cell transplant + chemotherapy Accommodation days: 53 days Treatment cost: approximately 1698690 yuan Treatment effect: Complete alleviation Dr. Kenneth is from Malaysia and was diagnosed with Fabre disease locally.

Upon arrival, the International Medical Services Team arranged for the first time multidisciplinary MDT for patients, developed individualized clinical pathways based on the patient's examination reports and physical condition, and provided translation, escort and on-site services throughout the treatment process. The MDT Expert Group uses a comprehensive set of blood stem cell transplants + chemotherapy, and during the treatment the medical team closely monitors the patient's indicators and dynamic adjustment programs. After 53 days of systemic treatment and rehabilitation management, the patient's condition gradually improved, and the test indicators returned to normal areas, successfully reaching the hospital standard.

Treatment results were finally completely alleviated. When the patient was discharged, the medical team developed a detailed return follow-up and rehabilitation plan for him and continued to monitor the recovery through the remote follow-up system. 'Mr.

J. Kenneth, experts have criticized this case as a typical case of cross-border suspected seriousness clinical cases. The J4T relies on a multidisciplinary collaborative mechanism to develop a blood stem cell transplant + chemotherapy program for Febre's disease, which reflects the comprehensive strength of Chinese hospitals in the field of suspected diagnostics and a summary of how international medical services are regulated.

(Figures from J5T official news reports and medical scenarios)

马来西亚,法布雷病,北京大学第三医院,国际医疗,来华就医,中国医疗